The Cannabis Company

21 June 2020 By PDSNET

Until September last year, you could easily be forgiven for not paying much attention to the thinly traded penny stock, Labat. Styling itself as an “investment holding company” it seemed to have a diverse collection of businesses which did not hold much potential and lacked a clear focus.

In September 2019, however, it changed its focus and decided to become a “fully integrated cannabis business”. It was looking to cultivate, harvest, process and export cannabis from Lesotho for medicinal and pharmaceutical purposes.

It has acquired a collection of companies which make this new goal possible and give JSE investors the only listed company which is actively seeking to focus on and exploit the cannabis market.

On 14th April 2020 the company acquired 70% of Biodata, an East London based company which is focused on cannabinoid healing for pain management and insomnia. The acquisition was made for shares.

Nobody quite knows what the cannabis market will be worth in South Africa but the export potential for high-quality cannabinoids appears to be almost limitless. It is estimated that here in South Africa the market is perhaps worth about R27bn.

On 5th May 2020 the company issued a forecast of its future profits for the years ending 31st August 2021 and 2022 which they had produced as part of their road-show to raise funds from institutional investors. In those forecasts, they predicted that they would generate headline earnings per share (HEPS) of 10,9c in 2021 and 29,9c in 2022 – which is very impressive when its share price is just 46c.

Clearly, somebody believes these forecasts because the share’s price has suddenly jumped from around 30c to 46c in the last few days on very strong volumes traded.

In technical analysis, a rising share price which is accompanied by sharp increases in volume is an indication of insiders buying up the share. The “weak hands” are being bought out by the “strong hands”. Consider the chart:

Labat - On balance volume (OBV) 20/02/2020-18-06-2020

The top chart is a simple candlestick chart of the share’s daily price action, showing the sharp upward move. The middle chart shows it’s on balance volume (OBV) which is calculated by adding volumes to a running total on days when the share’s price rises and subtracting them on days when it falls. A sharp rise in the OBV is an indication that insiders are buying up all loosely held shares in the market. Finally, the bottom chart is a volume histogram which shows the daily volume of shares changing hands. This last chart shows how average volumes have increased sharply in the last week or so – and these volumes have been accompanied by a sharp rise in the share’s price.

All of this means that this share now represents an opportunity. Of course, there is risk, but there can be little doubt that cannabis is steadily becoming legalized throughout the world and the potential for its medicinal and leisure usage represents a huge opportunity. The increased volumes traded in the share now make it practical for private investors to buy.


DISCLAIMER

All information and data contained within the PDSnet Articles is for informational purposes only. PDSnet makes no representations as to the accuracy, completeness, suitability, or validity, of any information, and shall not be liable for any errors, omissions, or any losses, injuries, or damages arising from its display or use. Information in the PDSnet Articles are based on the author’s opinion and experience and should not be considered professional financial investment advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional. Thoughts and opinions will also change from time to time as more information is accumulated. PDSnet reserves the right to delete any comment or opinion for any reason.



Share this article:

PDSNET ARTICLES

Stadio

When it listed on the JSE, Stadio was one of those shares which was widely perceived to have almost unlimited “blue sky” potential. Riding on the back of Curro’s success and Chris van der Merwe’s (the CEO at that time) reputation, it was thought that Stadio would do as well as Curro, if not better. Like Curro, it was thought that there was a virtually no limit to Stadio’s potential

The Confidential Report - July 2020

America

A week ago, world markets were discounting a rapid recovery from the COVID-19 pandemic. Then the number of cases in America began to spike up. Until the middle of June there had been a steady downward trend and then suddenly the number of cases began to rise with 31 000 on the 20th of June, 33 000 on the 23rd, almost

Rand Recovery

The rand is arguably one of the most volatile and difficult currencies to predict. It is very liquid and is the preferred emerging market currency of international currency speculators. It has become a ping-pong ball which reflects the spasmodic shifts between “risk-on” and “risk-off” sentiment on the world stage.
If international investors get scared, then the rand

Covid in Context

It is perhaps a good time to stand back from the hectic and extraordinary events that have accompanied the corona pandemic and try to put them into some sort of context from an investment perspective. It is steadily becoming more and more certain that the corona bear trend (if we can even call it that) has been short and sharp and completely unlike any previous bear trend in history. This is because it was not brought

The Confidential Report - June 2020

America

From an economic perspective, America seems to experiencing the first signs of return to normality. The following is a selection of the more visible signs:
  • Panic buying of toilet rolls, disinfectants and food is down by over 60%.
  • Clothing and accessories sales are up over 600%.
  • The Texas Manufacturing Outlook survey jumped 34% from April to May.
  • Road

Afrimat Opportunity

Afrimat (AFT) is a share that we have liked for a long time. In May last year we wrote an article in which we did a point-and-figure horizontal count on its upside breakout from a lengthy period of sideways movement. Unfortunately, the coronavirus made a nonsense of our predictions, but the underlying fundamentals of this company have only improved since then and it now represents one of the

The Prosus Winner

It has been well said that no matter what happens in the world or in South Africa, there is always a way to make money from it in the share market - it is just a matter of seeing where the opportunity lies.
The advent of the coronavirus in late January this year, while it was a world-wide human and economic catastrophe, presented just such an opportunity. The contagion forced a sea-change in behaviour patterns world-wide

R186 Long Bond

Sometimes things happen in the markets which cause you to ask the question,
"What can they see that I can't see?"
The progress of the yield on South Africa's long bonds is like that.
South Africa has just been downgraded by both Moodys and Standard & Poors. We are officially at junk status - so you would think that our government debt instruments would be out of favour among international

Imperial Logistics

Imperial (IPL) is a large international logistics company with 27 000 employees operating in 32 countries mainly in Africa and Europe. In is involved in transport, warehousing and international freight management. It is the largest logistics supplier in South Africa. The company is involved in five key areas - automotive, chemicals, consumer, healthcare and industrial.
The company recently split off and separately listed

The Confidential Report - May 2020

Wall Street

It is becoming clear that the lack of nation-wide response to COVID19 in America is now endangering the entire world economy. It is apparent that the virus is going to have a much greater and more prolonged impact in the US than was originally expected. This is mostly because of the patchy lockdowns and the state-by-state response. There have been no useful nation-wide directives